S3797Referred to Committee

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-02-05
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Richard J. Durbin
Richard J. Durbin
Democrat · IL · Senator
Votes with party: 56.8% (322 recorded votes)

Full profile: /officials/D000563

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S512)

2026-02-05

Source: Congress.gov

Plain-English Summary

This bill would ban the sale and distribution of tianeptine, a drug sometimes sold as a dietary supplement or nootropic that can cause addiction and serious health problems, along with other potentially dangerous products. The ban would apply to retailers, online sellers, and manufacturers who currently market these substances to consumers. The legislation aims to protect public health by preventing access to drugs that lack proper FDA approval and oversight.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.